Phenotypes of COPD patients with a smoking history in Central
and Eastern Europe: the POPE Study

J 2017

Phenotypes of COPD patients with a smoking history in Central and Eastern Europe: the POPE Study

KOBLIZEK, Vladimir; Branislava MILENKOVIC; Adam BARCZYK; Ruzena TKACOVA; Attila SOMFAY et. al.

Základní údaje

Originální název

Phenotypes of COPD patients with a smoking history in Central and Eastern Europe: the POPE Study

Autoři

Vydání

European Respiratory Journal, Sheffield, European Respiratory Society Journals Ltd. 2017, 0903-1936

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30203 Respiratory systems

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 12.244

Kód RIV

RIV/00216224:14110/17:00096971

Organizační jednotka

Lékařská fakulta

DOI

https://doi.org/10.1183/13993003.01446-2016

UT WoS

000401788800005

EID Scopus

2-s2.0-85019077682

Klíčová slova anglicky

Chronic obstructive pulmonary disease

Štítky

EL OK

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 20. 3. 2018 17:32, Soňa Böhmová

Anotace

V originále

Chronic obstructive pulmonary disease (COPD) represents a major health problem in Central and Eastern European (CEE) countries; however, there are no data regarding clinical phenotypes of these patients in this region. Participation in the Phenotypes of COPD in Central and Eastern Europe (POPE) study was offered to stable patients with COPD in a real-life setting. The primary aim of this study was to assess the prevalence of phenotypes according to predefined criteria. Secondary aims included analysis of differences in symptom load, comorbidities and pharmacological treatment. 3362 patients with COPD were recruited in 10 CEE countries. 63% of the population were nonexacerbators, 20.4% frequent exacerbators with chronic bronchitis, 9.5% frequent exacerbators without chronic bronchitis and 6.9% were classified as asthma-COPD overlap. Differences in the distribution of phenotypes between countries were observed, with the highest heterogeneity observed in the nonexacerbator cohort and the lowest heterogeneity observed in the asthma-COPD cohort. There were statistically significant differences in symptom load, lung function, comorbidities and treatment between these phenotypes. The majority of patients with stable COPD in CEE are nonexacerbators; however, there are distinct differences in surrogates of disease severity and therapy between predefined COPD phenotypes.

Citovat

KOBLIZEK, Vladimir; Branislava MILENKOVIC; Adam BARCZYK; Ruzena TKACOVA; Attila SOMFAY; Kirill ZYKOV; Neven TUDORIC; Kosta KOSTOV; Zuzana ZBOŽÍNKOVÁ; Jan ŠVANCARA; Jurij SORLI; Alvils KRAMS; Marc MIRAVITLLES a Arschang VALIPOUR. Phenotypes of COPD patients with a smoking history in Central and Eastern Europe: the POPE Study. European Respiratory Journal. Sheffield: European Respiratory Society Journals Ltd., 2017, roč. 49, č. 5, s. 1-10. ISSN 0903-1936. Dostupné z: https://doi.org/10.1183/13993003.01446-2016.

@article{1383148,
   author = {Koblizek, Vladimir and Milenkovic, Branislava and Barczyk, Adam and Tkacova, Ruzena and Somfay, Attila and Zykov, Kirill and Tudoric, Neven and Kostov, Kosta and Zbožínková, Zuzana and Švancara, Jan and Sorli, Jurij and Krams, Alvils and Miravitlles, Marc and Valipour, Arschang},
   article_location = {Sheffield},
   article_number = {5},
   doi = {https://doi.org/10.1183/13993003.01446-2016},
   keywords = {Chronic obstructive pulmonary disease},
   language = {eng},
   issn = {0903-1936},
   journal = {European Respiratory Journal},
   title = {Phenotypes of COPD patients with a smoking history in Central and Eastern Europe: the POPE Study},
   volume = {49},
   year = {2017}
}

TY  - JOUR
ID  - 1383148
AU  - Koblizek, Vladimir - Milenkovic, Branislava - Barczyk, Adam - Tkacova, Ruzena - Somfay, Attila - Zykov, Kirill - Tudoric, Neven - Kostov, Kosta - Zbožínková, Zuzana - Švancara, Jan - Sorli, Jurij - Krams, Alvils - Miravitlles, Marc - Valipour, Arschang
PY  - 2017
TI  - Phenotypes of COPD patients with a smoking history in Central and Eastern Europe: the POPE Study
JF  - European Respiratory Journal
VL  - 49
IS  - 5
SP  - 1-10
EP  - 1-10
PB  - European Respiratory Society Journals Ltd.
SN  - 09031936
KW  - Chronic obstructive pulmonary disease
N2  - Chronic obstructive pulmonary disease (COPD) represents a major health problem in Central and Eastern European (CEE) countries; however, there are no data regarding clinical phenotypes of these patients in this region. Participation in the Phenotypes of COPD in Central and Eastern Europe (POPE) study was offered to stable patients with COPD in a real-life setting. The primary aim of this study was to assess the prevalence of phenotypes according to predefined criteria. Secondary aims included analysis of differences in symptom load, comorbidities and pharmacological treatment. 3362 patients with COPD were recruited in 10 CEE countries. 63% of the population were nonexacerbators, 20.4% frequent exacerbators with chronic bronchitis, 9.5% frequent exacerbators without chronic bronchitis and 6.9% were classified as asthma-COPD overlap. Differences in the distribution of phenotypes between countries were observed, with the highest heterogeneity observed in the nonexacerbator cohort and the lowest heterogeneity observed in the asthma-COPD cohort. There were statistically significant differences in symptom load, lung function, comorbidities and treatment between these phenotypes. The majority of patients with stable COPD in CEE are nonexacerbators; however, there are distinct differences in surrogates of disease severity and therapy between predefined COPD phenotypes.
ER  -

KOBLIZEK, Vladimir; Branislava MILENKOVIC; Adam BARCZYK; Ruzena TKACOVA; Attila SOMFAY; Kirill ZYKOV; Neven TUDORIC; Kosta KOSTOV; Zuzana ZBOŽÍNKOVÁ; Jan ŠVANCARA; Jurij SORLI; Alvils KRAMS; Marc MIRAVITLLES a Arschang VALIPOUR. Phenotypes of COPD patients with a smoking history in Central and Eastern Europe: the POPE Study. \textit{European Respiratory Journal}. Sheffield: European Respiratory Society Journals Ltd., 2017, roč.~49, č.~5, s.~1-10. ISSN~0903-1936. Dostupné z: https://doi.org/10.1183/13993003.01446-2016.

Přehled o publikaci